COVID-19 Impact on Global Genetic Modification Therapies Market Size, Status and Forecast 2020-2026
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Genetic Modification Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Genetic Modification Therapies industry.
Based on our recent survey, we have several different scenarios about the Genetic Modification Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Genetic Modification Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Modification Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Modification Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Genetic Modification Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Genetic Modification Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Genetic Modification Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Modification Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Modification Therapies market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Genetic Modification Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Genetic Modification Therapies industry.
Based on our recent survey, we have several different scenarios about the Genetic Modification Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Genetic Modification Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Modification Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Modification Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Genetic Modification Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Genetic Modification Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Genetic Modification Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Modification Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Modification Therapies market.
The following players are covered in this report:
- 4D Molecular Therapeutics
- Abeona Therapeutics
- Allergan
- American Gene Technologies
- Merck Millipore
- AbbVie
- Gene Therapies
- Genetically Modified Cell Therapies
- RNA Therapies
- Gene Editing
- Hospitals
- Diagnostics and Testing Laboratories
- Academic and Research Organizations
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genetic Modification Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Genetic Modification Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gene Therapies
1.4.3 Genetically Modified Cell Therapies
1.4.4 RNA Therapies
1.4.5 Gene Editing
1.5 Market by Application
1.5.1 Global Genetic Modification Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics and Testing Laboratories
1.5.4 Academic and Research Organizations
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Genetic Modification Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Genetic Modification Therapies Industry
1.6.1.1 Genetic Modification Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Genetic Modification Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Genetic Modification Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Genetic Modification Therapies Market Perspective (2015-2026)
2.2 Genetic Modification Therapies Growth Trends by Regions
2.2.1 Genetic Modification Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genetic Modification Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Genetic Modification Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genetic Modification Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Genetic Modification Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genetic Modification Therapies Players by Market Size
3.1.1 Global Top Genetic Modification Therapies Players by Revenue (2015-2020)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genetic Modification Therapies Market Concentration Ratio
3.2.1 Global Genetic Modification Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genetic Modification Therapies Revenue in 2019
3.3 Genetic Modification Therapies Key Players Head office and Area Served
3.4 Key Players Genetic Modification Therapies Product Solution and Service
3.5 Date of Enter into Genetic Modification Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Genetic Modification Therapies Historic Market Size by Type (2015-2020)
4.2 Global Genetic Modification Therapies Forecasted Market Size by Type (2021-2026)
5 GENETIC MODIFICATION THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Genetic Modification Therapies Market Size by Application (2015-2020)
5.2 Global Genetic Modification Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Genetic Modification Therapies Market Size (2015-2020)
6.2 Genetic Modification Therapies Key Players in North America (2019-2020)
6.3 North America Genetic Modification Therapies Market Size by Type (2015-2020)
6.4 North America Genetic Modification Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Genetic Modification Therapies Market Size (2015-2020)
7.2 Genetic Modification Therapies Key Players in Europe (2019-2020)
7.3 Europe Genetic Modification Therapies Market Size by Type (2015-2020)
7.4 Europe Genetic Modification Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Genetic Modification Therapies Market Size (2015-2020)
8.2 Genetic Modification Therapies Key Players in China (2019-2020)
8.3 China Genetic Modification Therapies Market Size by Type (2015-2020)
8.4 China Genetic Modification Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Genetic Modification Therapies Market Size (2015-2020)
9.2 Genetic Modification Therapies Key Players in Japan (2019-2020)
9.3 Japan Genetic Modification Therapies Market Size by Type (2015-2020)
9.4 Japan Genetic Modification Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Genetic Modification Therapies Market Size (2015-2020)
10.2 Genetic Modification Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genetic Modification Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Genetic Modification Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Genetic Modification Therapies Market Size (2015-2020)
11.2 Genetic Modification Therapies Key Players in India (2019-2020)
11.3 India Genetic Modification Therapies Market Size by Type (2015-2020)
11.4 India Genetic Modification Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Genetic Modification Therapies Market Size (2015-2020)
12.2 Genetic Modification Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Genetic Modification Therapies Market Size by Type (2015-2020)
12.4 Central & South America Genetic Modification Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 4D Molecular Therapeutics
13.1.1 4D Molecular Therapeutics Company Details
13.1.2 4D Molecular Therapeutics Business Overview and Its Total Revenue
13.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
13.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020))
13.1.5 4D Molecular Therapeutics Recent Development
13.2 Abeona Therapeutics
13.2.1 Abeona Therapeutics Company Details
13.2.2 Abeona Therapeutics Business Overview and Its Total Revenue
13.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
13.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020)
13.2.5 Abeona Therapeutics Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview and Its Total Revenue
13.3.3 Allergan Genetic Modification Therapies Introduction
13.3.4 Allergan Revenue in Genetic Modification Therapies Business (2015-2020)
13.3.5 Allergan Recent Development
13.4 American Gene Technologies
13.4.1 American Gene Technologies Company Details
13.4.2 American Gene Technologies Business Overview and Its Total Revenue
13.4.3 American Gene Technologies Genetic Modification Therapies Introduction
13.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2015-2020)
13.4.5 American Gene Technologies Recent Development
13.5 Merck Millipore
13.5.1 Merck Millipore Company Details
13.5.2 Merck Millipore Business Overview and Its Total Revenue
13.5.3 Merck Millipore Genetic Modification Therapies Introduction
13.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2015-2020)
13.5.5 Merck Millipore Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview and Its Total Revenue
13.6.3 AbbVie Genetic Modification Therapies Introduction
13.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2015-2020)
13.6.5 AbbVie Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genetic Modification Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Genetic Modification Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gene Therapies
1.4.3 Genetically Modified Cell Therapies
1.4.4 RNA Therapies
1.4.5 Gene Editing
1.5 Market by Application
1.5.1 Global Genetic Modification Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics and Testing Laboratories
1.5.4 Academic and Research Organizations
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Genetic Modification Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Genetic Modification Therapies Industry
1.6.1.1 Genetic Modification Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Genetic Modification Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Genetic Modification Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Genetic Modification Therapies Market Perspective (2015-2026)
2.2 Genetic Modification Therapies Growth Trends by Regions
2.2.1 Genetic Modification Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genetic Modification Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Genetic Modification Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genetic Modification Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Genetic Modification Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genetic Modification Therapies Players by Market Size
3.1.1 Global Top Genetic Modification Therapies Players by Revenue (2015-2020)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genetic Modification Therapies Market Concentration Ratio
3.2.1 Global Genetic Modification Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genetic Modification Therapies Revenue in 2019
3.3 Genetic Modification Therapies Key Players Head office and Area Served
3.4 Key Players Genetic Modification Therapies Product Solution and Service
3.5 Date of Enter into Genetic Modification Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Genetic Modification Therapies Historic Market Size by Type (2015-2020)
4.2 Global Genetic Modification Therapies Forecasted Market Size by Type (2021-2026)
5 GENETIC MODIFICATION THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Genetic Modification Therapies Market Size by Application (2015-2020)
5.2 Global Genetic Modification Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Genetic Modification Therapies Market Size (2015-2020)
6.2 Genetic Modification Therapies Key Players in North America (2019-2020)
6.3 North America Genetic Modification Therapies Market Size by Type (2015-2020)
6.4 North America Genetic Modification Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Genetic Modification Therapies Market Size (2015-2020)
7.2 Genetic Modification Therapies Key Players in Europe (2019-2020)
7.3 Europe Genetic Modification Therapies Market Size by Type (2015-2020)
7.4 Europe Genetic Modification Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Genetic Modification Therapies Market Size (2015-2020)
8.2 Genetic Modification Therapies Key Players in China (2019-2020)
8.3 China Genetic Modification Therapies Market Size by Type (2015-2020)
8.4 China Genetic Modification Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Genetic Modification Therapies Market Size (2015-2020)
9.2 Genetic Modification Therapies Key Players in Japan (2019-2020)
9.3 Japan Genetic Modification Therapies Market Size by Type (2015-2020)
9.4 Japan Genetic Modification Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Genetic Modification Therapies Market Size (2015-2020)
10.2 Genetic Modification Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genetic Modification Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Genetic Modification Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Genetic Modification Therapies Market Size (2015-2020)
11.2 Genetic Modification Therapies Key Players in India (2019-2020)
11.3 India Genetic Modification Therapies Market Size by Type (2015-2020)
11.4 India Genetic Modification Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Genetic Modification Therapies Market Size (2015-2020)
12.2 Genetic Modification Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Genetic Modification Therapies Market Size by Type (2015-2020)
12.4 Central & South America Genetic Modification Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 4D Molecular Therapeutics
13.1.1 4D Molecular Therapeutics Company Details
13.1.2 4D Molecular Therapeutics Business Overview and Its Total Revenue
13.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
13.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020))
13.1.5 4D Molecular Therapeutics Recent Development
13.2 Abeona Therapeutics
13.2.1 Abeona Therapeutics Company Details
13.2.2 Abeona Therapeutics Business Overview and Its Total Revenue
13.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
13.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020)
13.2.5 Abeona Therapeutics Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview and Its Total Revenue
13.3.3 Allergan Genetic Modification Therapies Introduction
13.3.4 Allergan Revenue in Genetic Modification Therapies Business (2015-2020)
13.3.5 Allergan Recent Development
13.4 American Gene Technologies
13.4.1 American Gene Technologies Company Details
13.4.2 American Gene Technologies Business Overview and Its Total Revenue
13.4.3 American Gene Technologies Genetic Modification Therapies Introduction
13.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2015-2020)
13.4.5 American Gene Technologies Recent Development
13.5 Merck Millipore
13.5.1 Merck Millipore Company Details
13.5.2 Merck Millipore Business Overview and Its Total Revenue
13.5.3 Merck Millipore Genetic Modification Therapies Introduction
13.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2015-2020)
13.5.5 Merck Millipore Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview and Its Total Revenue
13.6.3 AbbVie Genetic Modification Therapies Introduction
13.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2015-2020)
13.6.5 AbbVie Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Genetic Modification Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Genetic Modification Therapies Revenue
Table 3. Ranking of Global Top Genetic Modification Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genetic Modification Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gene Therapies
Table 6. Key Players of Genetically Modified Cell Therapies
Table 7. Key Players of RNA Therapies
Table 8. Key Players of Gene Editing
Table 9. COVID-19 Impact Global Market: (Four Genetic Modification Therapies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Genetic Modification Therapies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Genetic Modification Therapies Players to Combat Covid-19 Impact
Table 14. Global Genetic Modification Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Genetic Modification Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Genetic Modification Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Genetic Modification Therapies Market Share by Regions (2015-2020)
Table 18. Global Genetic Modification Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Genetic Modification Therapies Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Genetic Modification Therapies Market Growth Strategy
Table 24. Main Points Interviewed from Key Genetic Modification Therapies Players
Table 25. Global Genetic Modification Therapies Revenue by Players (2015-2020) (Million US$)
Table 26. Global Genetic Modification Therapies Market Share by Players (2015-2020)
Table 27. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Modification Therapies as of 2019)
Table 28. Global Genetic Modification Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Genetic Modification Therapies Product Solution and Service
Table 31. Date of Enter into Genetic Modification Therapies Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 34. Global Genetic Modification Therapies Market Size Share by Type (2015-2020)
Table 35. Global Genetic Modification Therapies Revenue Market Share by Type (2021-2026)
Table 36. Global Genetic Modification Therapies Market Size Share by Application (2015-2020)
Table 37. Global Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 38. Global Genetic Modification Therapies Market Size Share by Application (2021-2026)
Table 39. North America Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 41. North America Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 42. North America Genetic Modification Therapies Market Share by Type (2015-2020)
Table 43. North America Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 44. North America Genetic Modification Therapies Market Share by Application (2015-2020)
Table 45. Europe Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 47. Europe Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Genetic Modification Therapies Market Share by Type (2015-2020)
Table 49. Europe Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Genetic Modification Therapies Market Share by Application (2015-2020)
Table 51. China Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 52. China Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 53. China Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 54. China Genetic Modification Therapies Market Share by Type (2015-2020)
Table 55. China Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 56. China Genetic Modification Therapies Market Share by Application (2015-2020)
Table 57. Japan Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 59. Japan Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Genetic Modification Therapies Market Share by Type (2015-2020)
Table 61. Japan Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Genetic Modification Therapies Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 65. Southeast Asia Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Genetic Modification Therapies Market Share by Type (2015-2020)
Table 67. Southeast Asia Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Genetic Modification Therapies Market Share by Application (2015-2020)
Table 69. India Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 70. India Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 71. India Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 72. India Genetic Modification Therapies Market Share by Type (2015-2020)
Table 73. India Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 74. India Genetic Modification Therapies Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 77. Central & South America Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Genetic Modification Therapies Market Share by Type (2015-2020)
Table 79. Central & South America Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Genetic Modification Therapies Market Share by Application (2015-2020)
Table 81. 4D Molecular Therapeutics Company Details
Table 82. 4D Molecular Therapeutics Business Overview
Table 83. 4D Molecular Therapeutics Product
Table 84. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 85. 4D Molecular Therapeutics Recent Development
Table 86. Abeona Therapeutics Company Details
Table 87. Abeona Therapeutics Business Overview
Table 88. Abeona Therapeutics Product
Table 89. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 90. Abeona Therapeutics Recent Development
Table 91. Allergan Company Details
Table 92. Allergan Business Overview
Table 93. Allergan Product
Table 94. Allergan Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 95. Allergan Recent Development
Table 96. American Gene Technologies Company Details
Table 97. American Gene Technologies Business Overview
Table 98. American Gene Technologies Product
Table 99. American Gene Technologies Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 100. American Gene Technologies Recent Development
Table 101. Merck Millipore Company Details
Table 102. Merck Millipore Business Overview
Table 103. Merck Millipore Product
Table 104. Merck Millipore Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 105. Merck Millipore Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 1. Genetic Modification Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Genetic Modification Therapies Revenue
Table 3. Ranking of Global Top Genetic Modification Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genetic Modification Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gene Therapies
Table 6. Key Players of Genetically Modified Cell Therapies
Table 7. Key Players of RNA Therapies
Table 8. Key Players of Gene Editing
Table 9. COVID-19 Impact Global Market: (Four Genetic Modification Therapies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Genetic Modification Therapies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Genetic Modification Therapies Players to Combat Covid-19 Impact
Table 14. Global Genetic Modification Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Genetic Modification Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Genetic Modification Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Genetic Modification Therapies Market Share by Regions (2015-2020)
Table 18. Global Genetic Modification Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Genetic Modification Therapies Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Genetic Modification Therapies Market Growth Strategy
Table 24. Main Points Interviewed from Key Genetic Modification Therapies Players
Table 25. Global Genetic Modification Therapies Revenue by Players (2015-2020) (Million US$)
Table 26. Global Genetic Modification Therapies Market Share by Players (2015-2020)
Table 27. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Modification Therapies as of 2019)
Table 28. Global Genetic Modification Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Genetic Modification Therapies Product Solution and Service
Table 31. Date of Enter into Genetic Modification Therapies Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 34. Global Genetic Modification Therapies Market Size Share by Type (2015-2020)
Table 35. Global Genetic Modification Therapies Revenue Market Share by Type (2021-2026)
Table 36. Global Genetic Modification Therapies Market Size Share by Application (2015-2020)
Table 37. Global Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 38. Global Genetic Modification Therapies Market Size Share by Application (2021-2026)
Table 39. North America Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 41. North America Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 42. North America Genetic Modification Therapies Market Share by Type (2015-2020)
Table 43. North America Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 44. North America Genetic Modification Therapies Market Share by Application (2015-2020)
Table 45. Europe Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 47. Europe Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Genetic Modification Therapies Market Share by Type (2015-2020)
Table 49. Europe Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Genetic Modification Therapies Market Share by Application (2015-2020)
Table 51. China Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 52. China Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 53. China Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 54. China Genetic Modification Therapies Market Share by Type (2015-2020)
Table 55. China Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 56. China Genetic Modification Therapies Market Share by Application (2015-2020)
Table 57. Japan Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 59. Japan Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Genetic Modification Therapies Market Share by Type (2015-2020)
Table 61. Japan Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Genetic Modification Therapies Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 65. Southeast Asia Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Genetic Modification Therapies Market Share by Type (2015-2020)
Table 67. Southeast Asia Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Genetic Modification Therapies Market Share by Application (2015-2020)
Table 69. India Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 70. India Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 71. India Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 72. India Genetic Modification Therapies Market Share by Type (2015-2020)
Table 73. India Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 74. India Genetic Modification Therapies Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Genetic Modification Therapies Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Genetic Modification Therapies Market Share (2019-2020)
Table 77. Central & South America Genetic Modification Therapies Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Genetic Modification Therapies Market Share by Type (2015-2020)
Table 79. Central & South America Genetic Modification Therapies Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Genetic Modification Therapies Market Share by Application (2015-2020)
Table 81. 4D Molecular Therapeutics Company Details
Table 82. 4D Molecular Therapeutics Business Overview
Table 83. 4D Molecular Therapeutics Product
Table 84. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 85. 4D Molecular Therapeutics Recent Development
Table 86. Abeona Therapeutics Company Details
Table 87. Abeona Therapeutics Business Overview
Table 88. Abeona Therapeutics Product
Table 89. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 90. Abeona Therapeutics Recent Development
Table 91. Allergan Company Details
Table 92. Allergan Business Overview
Table 93. Allergan Product
Table 94. Allergan Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 95. Allergan Recent Development
Table 96. American Gene Technologies Company Details
Table 97. American Gene Technologies Business Overview
Table 98. American Gene Technologies Product
Table 99. American Gene Technologies Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 100. American Gene Technologies Recent Development
Table 101. Merck Millipore Company Details
Table 102. Merck Millipore Business Overview
Table 103. Merck Millipore Product
Table 104. Merck Millipore Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 105. Merck Millipore Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Genetic Modification Therapies Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Genetic Modification Therapies Market Share by Type: 2020 VS 2026
Figure 2. Gene Therapies Features
Figure 3. Genetically Modified Cell Therapies Features
Figure 4. RNA Therapies Features
Figure 5. Gene Editing Features
Figure 6. Global Genetic Modification Therapies Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostics and Testing Laboratories Case Studies
Figure 9. Academic and Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Genetic Modification Therapies Report Years Considered
Figure 12. Global Genetic Modification Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Genetic Modification Therapies Market Share by Regions: 2020 VS 2026
Figure 14. Global Genetic Modification Therapies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Genetic Modification Therapies Market Share by Players in 2019
Figure 17. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Modification Therapies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2019
Figure 19. North America Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. 4D Molecular Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 28. Abeona Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 30. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 32. American Gene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 34. Merck Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 36. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Figure 1. Global Genetic Modification Therapies Market Share by Type: 2020 VS 2026
Figure 2. Gene Therapies Features
Figure 3. Genetically Modified Cell Therapies Features
Figure 4. RNA Therapies Features
Figure 5. Gene Editing Features
Figure 6. Global Genetic Modification Therapies Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostics and Testing Laboratories Case Studies
Figure 9. Academic and Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Genetic Modification Therapies Report Years Considered
Figure 12. Global Genetic Modification Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Genetic Modification Therapies Market Share by Regions: 2020 VS 2026
Figure 14. Global Genetic Modification Therapies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Genetic Modification Therapies Market Share by Players in 2019
Figure 17. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Modification Therapies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2019
Figure 19. North America Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Genetic Modification Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. 4D Molecular Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 28. Abeona Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 30. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 32. American Gene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 34. Merck Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 36. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
